Market Cap 117.72M
Revenue (ttm) 0.00
Net Income (ttm) -10.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 140,217
Avg Vol 241,224
Day's Range N/A - N/A
Shares Out 34.02M
Stochastic %K 38%
Beta 0.59
Analysts Strong Sell
Price Target $10.00

Company Profile

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery pro...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 708 9808
Address:
3150 Almaden Expressway, Suite 250, San Jose, United States
SCUBus
SCUBus Jul. 29 at 12:33 AM
$ANIX Still in the Uptrend Channel Technically Speaking...
0 · Reply
nsiebers2011
nsiebers2011 Jul. 28 at 5:07 PM
$ANIX CEO Amit Kumar disclosed another open-market purchase in a Form 4 filed today — 5,000 shares at $3.44 on 7/27. That's his fifth purchase this month, 21,188 shares total, lifting his direct stake to 652,000. All open-market, none under a 10b5-1 plan. Filing: https://www.sec.gov/Archives/edgar/data/715446/000149315226034952/xslF345X06/ownership.xml
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jul. 28 at 4:25 PM
$ANIX CEO purchased 5,000 shares at $3.44 for a total of $17,200. KUMAR AMIT now owns 652,000 shares. https://ceo-buys.com
0 · Reply
kubota2323
kubota2323 Jul. 28 at 4:09 PM
$ANIX added a few bags.
0 · Reply
tyrus6
tyrus6 Jul. 28 at 2:49 PM
$ANIX Relentless confidence in his company producing a worldwide breast cancer vaccine on display.
0 · Reply
bioinvestorrr
bioinvestorrr Jul. 28 at 2:42 PM
$ANIX 5k shares purchased yesterday by CEO. Interesting
0 · Reply
SCUBus
SCUBus Jul. 28 at 2:27 PM
$ANIX Chairman and CEO Kumar bought ANOTHER 5,000 shares yesterday at $3.44 / share. That's on top of the 3,188 shares bought earlier in the day at $3.37 / share. A total of 8,188 shares for the day yesterday ($27,943 total cash out of his pocket!). Clearly he is a believer. Now owns 652,000 shares (not counting his stock options).
0 · Reply
SCUBus
SCUBus Jul. 27 at 11:38 PM
$ANIX Still in an UPTREND. Bounced off the lower band of the channel today. CEO Kumar keeps buying. Two days in a row. A $1 billion valuation would be ~$30/share (10X from here).
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jul. 27 at 9:30 PM
$ANIX CEO purchased 3,188 shares at $3.37 for a total of $10,744. KUMAR AMIT now owns 647,000 shares. https://ceo-buys.com
0 · Reply
bioinvestorrr
bioinvestorrr Jul. 27 at 8:43 PM
$ANIX more stock purchases, thats now another 6k added
0 · Reply
Latest News on ANIX
Anixa Biosciences assumed with a Buy at D. Boral Capital

2026-06-30T08:55:08.000Z - 4 weeks ago

Anixa Biosciences assumed with a Buy at D. Boral Capital


Anixa Biosciences Quarterly report: Q2 2026

Jun 10, 2026, 7:00 AM EDT - 7 weeks ago

Anixa Biosciences Quarterly report: Q2 2026


Anixa Biosciences Slides: Corporate presentation

Jun 4, 2026, 7:00 AM EDT - 7 weeks ago

Anixa Biosciences Slides: Corporate presentation


Anixa Biosciences: CIPO issues Notice of Allowance for patent

2026-06-01T14:17:37.000Z - 2 months ago

Anixa Biosciences: CIPO issues Notice of Allowance for patent


Anixa Biosciences Slides: Corporate presentation

Apr 14, 2026, 7:00 AM EDT - 3 months ago

Anixa Biosciences Slides: Corporate presentation


Anixa Biosciences announces agreement with Cytovance Biologics

2026-04-01T12:59:01.000Z - 4 months ago

Anixa Biosciences announces agreement with Cytovance Biologics


Anixa Biosciences Transcript: AGM 2026

Mar 10, 2026, 1:00 PM EDT - 5 months ago

Anixa Biosciences Transcript: AGM 2026


Anixa Biosciences Slides: FY 2026

Mar 10, 2026, 1:00 PM EDT - 5 months ago

Anixa Biosciences Slides: FY 2026


Anixa Biosciences Slides: Corporate presentation

Mar 10, 2026, 7:00 AM EDT - 5 months ago

Anixa Biosciences Slides: Corporate presentation


Anixa Biosciences Quarterly report: Q1 2026

Mar 9, 2026, 7:00 AM EDT - 5 months ago

Anixa Biosciences Quarterly report: Q1 2026


Anixa Biosciences Transcript: Fireside chat

Feb 10, 2026, 11:00 AM EST - 6 months ago

Anixa Biosciences Transcript: Fireside chat


Anixa Biosciences Press release: Fireside chat

Feb 10, 2026, 11:00 AM EST - 6 months ago

Anixa Biosciences Press release: Fireside chat


Anixa Biosciences Slides: Corporate presentation

Feb 7, 2026, 6:00 AM EST - 6 months ago

Anixa Biosciences Slides: Corporate presentation


Anixa Biosciences Proxy statement: Proxy Filing

Jan 28, 2026, 7:00 AM EST - 6 months ago

Anixa Biosciences Proxy statement: Proxy Filing


Anixa Biosciences Slides: Investor presentation

Jan 16, 2026, 7:00 AM EST - 6 months ago

Anixa Biosciences Slides: Investor presentation


Anixa Biosciences Annual report: Q4 2025

Jan 12, 2026, 7:00 AM EST - 7 months ago

Anixa Biosciences Annual report: Q4 2025


Anixa Biosciences Slides: Corporate Presentation

Nov 17, 2025, 7:00 AM EST - 9 months ago

Anixa Biosciences Slides: Corporate Presentation


Anixa Biosciences Transcript: Fireside Chat

Nov 11, 2025, 2:00 PM EST - 9 months ago

Anixa Biosciences Transcript: Fireside Chat


Anixa Biosciences executes data transfer with Cleveland Clinic

2025-11-05T14:01:35.000Z - 9 months ago

Anixa Biosciences executes data transfer with Cleveland Clinic


Anixa Biosciences Registration statement: Registration Filing

Sep 10, 2025, 8:00 AM EDT - 11 months ago

Anixa Biosciences Registration statement: Registration Filing


Anixa Biosciences Quarterly report: Q3 2025

Sep 10, 2025, 7:00 AM EDT - 11 months ago

Anixa Biosciences Quarterly report: Q3 2025


Anixa Biosciences Transcript: Status Update

Jun 26, 2025, 2:00 PM EDT - 1 year ago

Anixa Biosciences Transcript: Status Update


SCUBus
SCUBus Jul. 29 at 12:33 AM
$ANIX Still in the Uptrend Channel Technically Speaking...
0 · Reply
nsiebers2011
nsiebers2011 Jul. 28 at 5:07 PM
$ANIX CEO Amit Kumar disclosed another open-market purchase in a Form 4 filed today — 5,000 shares at $3.44 on 7/27. That's his fifth purchase this month, 21,188 shares total, lifting his direct stake to 652,000. All open-market, none under a 10b5-1 plan. Filing: https://www.sec.gov/Archives/edgar/data/715446/000149315226034952/xslF345X06/ownership.xml
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jul. 28 at 4:25 PM
$ANIX CEO purchased 5,000 shares at $3.44 for a total of $17,200. KUMAR AMIT now owns 652,000 shares. https://ceo-buys.com
0 · Reply
kubota2323
kubota2323 Jul. 28 at 4:09 PM
$ANIX added a few bags.
0 · Reply
tyrus6
tyrus6 Jul. 28 at 2:49 PM
$ANIX Relentless confidence in his company producing a worldwide breast cancer vaccine on display.
0 · Reply
bioinvestorrr
bioinvestorrr Jul. 28 at 2:42 PM
$ANIX 5k shares purchased yesterday by CEO. Interesting
0 · Reply
SCUBus
SCUBus Jul. 28 at 2:27 PM
$ANIX Chairman and CEO Kumar bought ANOTHER 5,000 shares yesterday at $3.44 / share. That's on top of the 3,188 shares bought earlier in the day at $3.37 / share. A total of 8,188 shares for the day yesterday ($27,943 total cash out of his pocket!). Clearly he is a believer. Now owns 652,000 shares (not counting his stock options).
0 · Reply
SCUBus
SCUBus Jul. 27 at 11:38 PM
$ANIX Still in an UPTREND. Bounced off the lower band of the channel today. CEO Kumar keeps buying. Two days in a row. A $1 billion valuation would be ~$30/share (10X from here).
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jul. 27 at 9:30 PM
$ANIX CEO purchased 3,188 shares at $3.37 for a total of $10,744. KUMAR AMIT now owns 647,000 shares. https://ceo-buys.com
0 · Reply
bioinvestorrr
bioinvestorrr Jul. 27 at 8:43 PM
$ANIX more stock purchases, thats now another 6k added
0 · Reply
tyrus6
tyrus6 Jul. 27 at 5:20 PM
$ANIX ANIX & Cleveland Clinic offering the world what's very likely a MULTI- $BILLION breast cancer vaccine. (Aside from their positive results on ovarian cancer fighting treatment.) “We would love to give this shot to every woman in the world, who is worried about breast cancer, just like we’ve done with polio, small pox, measles and so forth and eliminate, I mean, this is a big vision, but eliminate breast cancer as a disease,” Kumar said. “This vaccine is designed to not only treat patients who have cancer, but also prevent cancer arising. Prevent recurrence as well as prevent cancer in women who’ve never had cancer before,” said Kumar. Early results from the first phase are encouraging. Every participant showed some level of an immune response, with only minor side effects. “That was a very, very powerful finding for phase one,” said Kumar. https://www.wptv.com/news/treasure-coast/patient-who-received-breast-cancer-vaccine-as-part-of-clinical-trial-speaks-about-experience
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jul. 27 at 3:05 PM
$ANIX CEO purchased 3,000 shares at $3.73 for a total of $11,190. KUMAR AMIT now owns 643,812 shares. https://ceo-buys.com
0 · Reply
bioinvestorrr
bioinvestorrr Jul. 27 at 2:06 PM
$ANIX more buying from ceo from friday
0 · Reply
nsiebers2011
nsiebers2011 Jul. 27 at 1:22 PM
$ANIX More insider buying from CEO! https://ir.anixa.com/sec-filings#document-23533-0001493152-26-034723
0 · Reply
SCUBus
SCUBus Jul. 24 at 11:51 PM
$ANIX UPTREND STILL INTACT! It was a slight down day, but one with another higher high and higher low on increasing volume. Still hugging the upper channel boundary.
0 · Reply
tyrus6
tyrus6 Jul. 24 at 3:46 PM
$ANIX There were two more insider purchases this week. Again by CEO Amit Kumar and Director Lewis Titterton. # # # Based on the most recent SEC filings and ownership reports: Institutional ownership: approximately 29% of outstanding shares. Insider ownership: approximately 26% (including officers and directors). Meaning roughly 55% of the company is held by institutions and insiders combined, leaving only about 45% as the public float. Some notable institutional holders include: Vanguard Group Geode Capital Management UBS Group Bank of America Renaissance Technologies A few additional observations that stand out: CEO Amit Kumar has continued to buy shares in the open market during 2026 rather than selling. Director Lewis Titterton has also made multiple open-market purchases this year. For a $127 million market cap biotech, I consider this ownership profile to be quite favorable... The freely tradable share count is relatively limited.
1 · Reply
tyrus6
tyrus6 Jul. 24 at 2:36 PM
$ANIX ChatGpt: "Why I think $150–190 million is reasonable today The market is beginning to recognize several positives: The company has multiple oncology assets, not just a single-shot program. The ovarian cancer CAR-T approach addresses a large unmet need. The breast cancer vaccine program provides additional optionality. Management has been buying stock personally, which is usually a bullish signal. CEO Amit Kumar has repeatedly emphasized minimizing cash burn and has been unusually transparent with shareholders. The company appears willing to pursue partnerships instead of trying to commercialize everything alone, which could significantly reduce financing risk. At $127M, the market is still assigning relatively little value to a pipeline that could produce several important clinical catalysts."
1 · Reply
tyrus6
tyrus6 Jul. 24 at 2:25 PM
$ANIX Was eyeing this for a week before buying in heavy today. My bid for 3.68 sat there for all premarket and then after the bell for 20 some minutes, sweating that it would take off to $ 4+ plus any second. I pulled the bid and was able to get in at $3.72 The coming price surge may happen again later today, maybe next week, is fine. But my studying up on Anixa found, very conservatively it ought to be trading at least a $ 170M market cap, or $5+ a share now.
0 · Reply
SCUBus
SCUBus Jul. 23 at 10:04 PM
$ANIX ABSOLUTELY PERFECT DAY! Higher high and another higher low on more than double the average Volume. Look at $ANIX hug the upper boundary of the uptrend channel. In case you haven't been following, I drew this uptrend channel over two weeks ago (check my prior posts if you don't believe me) Next stop $4.00+ ???
0 · Reply
bioinvestorrr
bioinvestorrr Jul. 23 at 8:42 PM
$ANIX interesting spike today
0 · Reply
bioinvestorrr
bioinvestorrr Jul. 23 at 7:08 PM
$ANIX what happened
0 · Reply
EthanH199
EthanH199 Jul. 23 at 7:07 PM
0 · Reply